Mereo BioPharma Group PLC (MREO)

3.82 -0.23 (-5.68%) USD  |  NASDAQ  |  Nov 14, 16:00
3.77 -0.05 (-1.31%) Pre-Market: 08:43
More

Mereo BioPharma Group Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Operating Income (TTM) Data

View and export this data back to 2024. Upgrade now.
Date Value
June 30, 2024 --

Operating Income Definition

Profit earned from a company's core business operations. It is gross profit less all operating expenses and depreciation.

Read full definition.

Operating Income (TTM) Range, Past 5 Years

Upgrade
Minimum
Jun 2024
Upgrade
Maximum
Jun 2024
Upgrade
Average
Upgrade
Median
Jun 2024

Operating Income (TTM) Benchmarks

NuCana PLC Upgrade
TC BioPharm (Holdings) PLC --
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC Upgrade
Autolus Therapeutics PLC Upgrade